Atossa Genetics is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. They believe that their innovative therapies and delivery methods can transform breast cancer treatment– with the goals of preventing breast cancer from developing in the first place, to increasing the odds of surviving for those who do develop this deadly disease.
Back to All Events
Earlier Event: June 17
Atossa Genetics (NASDAQ: ATOS) Logan Keynote Speaker Dinner Event
Later Event: July 17
Hecla Mining Company (NYSE: HL) Logan Keynote Speaker Dinner Event